[1]
Booth JS, Goldberg E, Patil SA, Barnes RS, Greenwald BD, Sztein MB. Effect of the live oral attenuated typhoid vaccine, Ty21a, on systemic and terminal ileum mucosal CD4+ T memory responses in humans. International immunology. 2019 Feb 15:31(2):101-116. doi: 10.1093/intimm/dxy070. Epub
[PubMed PMID: 30346608]
[2]
Masuet-Aumatell C, Atouguia J. Typhoid fever infection - Antibiotic resistance and vaccination strategies: A narrative review. Travel medicine and infectious disease. 2021 Mar-Apr:40():101946. doi: 10.1016/j.tmaid.2020.101946. Epub 2020 Dec 8
[PubMed PMID: 33301931]
Level 3 (low-level) evidence
[3]
Hughes MJ, Birhane MG, Dorough L, Reynolds JL, Caidi H, Tagg KA, Snyder CM, Yu AT, Altman SM, Boyle MM, Thomas D, Robbins AE, Waechter HA, Cody I, Mintz ED, Gutelius B, Langley G, Francois Watkins LK. Extensively Drug-Resistant Typhoid Fever in the United States. Open forum infectious diseases. 2021 Dec:8(12):ofab572. doi: 10.1093/ofid/ofab572. Epub 2021 Nov 16
[PubMed PMID: 34917695]
[4]
Simiyu K, Jamka L. Typhoid in a Kenyan Village: Its Impact, Its Prevention. The American journal of tropical medicine and hygiene. 2018 Nov:99(5):1112-1113. doi: 10.4269/ajtmh.18-0537. Epub
[PubMed PMID: 30404685]
[5]
Jin C, Torresi J. Typhoid vaccine responses in travellers treated with immunosuppressive therapy. Journal of travel medicine. 2018 Jan 1:25(1):. doi: 10.1093/jtm/tay090. Epub
[PubMed PMID: 30325433]
[6]
Milligan R, Paul M, Richardson M, Neuberger A. Vaccines for preventing typhoid fever. The Cochrane database of systematic reviews. 2018 May 31:5(5):CD001261. doi: 10.1002/14651858.CD001261.pub4. Epub 2018 May 31
[PubMed PMID: 29851031]
Level 1 (high-level) evidence
[7]
Britto CD, Wong VK, Dougan G, Pollard AJ. A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS neglected tropical diseases. 2018 Oct:12(10):e0006779. doi: 10.1371/journal.pntd.0006779. Epub 2018 Oct 11
[PubMed PMID: 30307935]
Level 1 (high-level) evidence
[8]
Theiss-Nyland K, Shakya M, Colin-Jones R, Voysey M, Smith N, Karkey A, Dongol S, Pant D, Farooq YG, Mazur O, Darlow C, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ. Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Nov 16:73(10):1950. doi: 10.1093/cid/ciab802. Epub
[PubMed PMID: 34698813]
Level 1 (high-level) evidence
[9]
Angelo KM, Haulman NJ, Terry AC, Leung DT, Chen LH, Barnett ED, Hagmann SHF, Hynes NA, Connor BA, Anderson S, McCarthy A, Shaw M, Van Genderen PJJ, Hamer DH. Illness among US resident student travellers after return to the USA: a GeoSentinel analysis, 2007-17. Journal of travel medicine. 2018 Jan 1:25(1):. doi: 10.1093/jtm/tay074. Epub
[PubMed PMID: 30202952]
[10]
Bentsi-Enchill AD, Pollard AJ. A Turning Point in Typhoid Control. The Journal of infectious diseases. 2018 Nov 10:218(suppl_4):S185-S187. doi: 10.1093/infdis/jiy417. Epub
[PubMed PMID: 30189009]
[11]
Mazzone T, Celestini E, Fabi R, Pagano M, Serafini MA, Verdecchia P, Mastroiacovo P. Oral typhoid vaccine and pregnancy. Reproductive toxicology (Elmsford, N.Y.). 1994 May-Jun:8(3):278-80
[PubMed PMID: 8075518]
[12]
Arora M, Lakshmi R. Vaccines - safety in pregnancy. Best practice & research. Clinical obstetrics & gynaecology. 2021 Oct:76():23-40. doi: 10.1016/j.bpobgyn.2021.02.002. Epub 2021 Feb 19
[PubMed PMID: 33773923]
[14]
Mogasale VV, Ramani E, Mogasale V, Park JY, Wierzba TF. Estimating Typhoid Fever Risk Associated with Lack of Access to Safe Water: A Systematic Literature Review. Journal of environmental and public health. 2018:2018():9589208. doi: 10.1155/2018/9589208. Epub 2018 Jul 4
[PubMed PMID: 30174699]
Level 1 (high-level) evidence
[15]
Balasubramanian R, Im J, Lee JS, Jeon HJ, Mogeni OD, Kim JH, Rakotozandrindrainy R, Baker S, Marks F. The global burden and epidemiology of invasive non-typhoidal Salmonella infections. Human vaccines & immunotherapeutics. 2019:15(6):1421-1426. doi: 10.1080/21645515.2018.1504717. Epub 2018 Sep 5
[PubMed PMID: 30081708]